Loading...
XNAS
ICLR
Market cap14bUSD
Dec 04, Last price  
185.77USD
1D
-1.07%
1Q
6.23%
Jan 2017
147.03%
Name

ICON PLC

Chart & Performance

D1W1MN
XNAS:ICLR chart
P/E
17.92
P/S
1.71
EPS
10.36
Div Yield, %
Shrs. gr., 5y
8.85%
Rev. gr., 5y
24.17%
Revenues
8.28b
+1.99%
0455,597,000630,722,000865,248,000887,612,000900,044,000945,729,0001,115,006,0001,336,058,0001,503,316,0001,574,978,0001,666,487,0001,758,439,0002,595,777,0002,805,839,0002,797,288,0005,480,826,0007,741,386,0008,120,176,0008,281,676,000
Net income
791m
+29.26%
038,304,00055,963,00078,120,00094,299,00087,071,00022,880,00058,346,000102,812,000172,468,000239,539,000262,179,000272,944,000322,817,000373,986,000327,809,000153,185,000505,304,000612,335,000791,474,000
CFO
1.29b
+10.82%
25,209,00050,452,00042,966,00081,282,000255,070,00087,428,00020,191,000113,771,000221,227,000169,948,000279,531,000259,204,00048,741,000264,013,000412,541,000594,724,000829,142,000563,315,0001,161,027,0001,286,652,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
IPO date
May 15, 1998
Employees
41,160
Domiciled in
IE
Incorporated in
IE

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT